State Street’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $21.6M | Buy |
|
|||||
|
2025
Q2 | $11.1M | Buy |
|
|||||
|
2025
Q1 | $8.31M | Sell |
|
|||||
|
2024
Q4 | $18.8M | Buy |
|
|||||
|
2024
Q3 | $16M | Buy |
|
|||||
|
2024
Q2 | $1.35M | Sell |
|
|||||
|
2024
Q1 | $2.68M | Sell |
|
|||||
|
2023
Q4 | $2.55M | Sell |
|
|||||
|
2023
Q3 | $3.85M | Sell |
|
|||||
|
2023
Q2 | $49.9M | Buy |
|
|||||
|
2023
Q1 | $56M | Sell |
|
|||||
|
2022
Q4 | $68.7M | Buy |
|
|||||
|
2022
Q3 | $90.6M | Buy |
|
|||||
|
2022
Q2 | $129M | Buy |
|
|||||
|
2022
Q1 | $142M | Buy |
|
|||||
|
2021
Q4 | $132M | Buy |
|
|||||
|
2021
Q3 | $120M | Buy |
|
|||||
|
2021
Q2 | $134M | Buy |
|
|||||
|
2021
Q1 | $178M | Sell |
|
|||||
|
2020
Q4 | $192M | Buy |
|
|||||
|
2020
Q3 | $192M | Sell |
|
|||||
|
2020
Q2 | $176M | Buy |
|
|||||
|
2020
Q1 | $126M | Buy |
|
|||||
|
2019
Q4 | $111M | Buy |
|
|||||
|
2019
Q3 | $96.6M | Sell |
|
|||||
|
2019
Q2 | $124M | Buy |
|
|||||
|
2019
Q1 | $113M | Buy |
|
|||||
|
2018
Q4 | $117M | Buy |
|
|||||
|
2018
Q3 | $125M | Sell |
|
|||||
|
2018
Q2 | $99.5M | Buy |
|
|||||
|
2018
Q1 | $91.1M | Buy |
|
|||||
|
2017
Q4 | $69.6M | Buy |
|
|||||
|
2017
Q3 | $57.2M | Buy |
|
|||||
|
2017
Q2 | $46.6M | Sell |
|
|||||
|
2017
Q1 | $42.2M | Buy |
|
|||||
|
2016
Q4 | $40.7M | Sell |
|
|||||
|
2016
Q3 | $48.9M | Buy |
|
|||||
|
2016
Q2 | $30.2M | Sell |
|
|||||
|
2016
Q1 | $40M | Buy |
|
|||||
|
2015
Q4 | $35.7M | Sell |
|
|||||
|
2015
Q3 | $38.4M | Sell |
|
|||||
|
2015
Q2 | $47.3M | Buy |
|
|||||
|
2015
Q1 | $39.4M | Buy |
|
|||||
|
2014
Q4 | $29.7M | Sell |
|
|||||
|
2014
Q3 | $24.6M | Sell |
|
|||||
|
2014
Q2 | $27.4M | Sell |
|
|||||
|
2014
Q1 | $31.7M | Buy |
|
|||||
|
2013
Q4 | $19.1M | Sell |
|
|||||
|
2013
Q3 | $16.8M | Sell |
|
|||||
|
2013
Q2 | $14M | Buy |
|